An animated look at how many people are taking retatrutide before any approval, and what that means for the gray market.
Recap by typeshit. Full story at The Infographics Show.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The drugs join more than 250 no-cost prescriptions on Walmart's medical plans next year, subject to prior approval.
An explainer on how appetite and weight can change after coming off GLP-1 drugs, and why any taper should be done with a doctor guiding it.
Loading…